z-logo
open-access-imgOpen Access
Utilization of H-bond interaction of nucleobase Uralic with antitumor methotrexate to design drug carrier with ultrahigh loading efficiency and pH-responsive drug release
Author(s) -
Tengteng Cai,
Qi Lei,
Bin Yang,
Huizhen Jia,
Hong Cheng,
LiHan Liu,
Xuan Zeng,
Jun Feng,
RenXi Zhuo,
XianZheng Zhang
Publication year - 2014
Publication title -
regenerative biomaterials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.166
H-Index - 25
ISSN - 2056-3426
DOI - 10.1093/rb/rbu010
Subject(s) - drug , ethylene glycol , methotrexate , anticancer drug , nanoparticle , copolymer , chemistry , combinatorial chemistry , materials science , pharmacology , nanotechnology , organic chemistry , biology , polymer , medicine
A novel Uralic (U)-rich linear-hyperbranched mono-methoxy poly (ethylene glycol)-hyperbranched polyglycerol-graft-Uralic (mPEG-HPG-g-U) nanoparticle (NP) was prepared as drug carrier for antitumor methotrexate (MTX). Due to the H-bond interaction of U with MTX and hydrophobic interaction, this NP exhibited high drug loading efficiency of up to 40%, which was significantly higher than that of traditional NPs based on U-absent copolymers (<15%). In addition, MTX-loaded mPEG-HPG-g-U NPs also demonstrated an acidity-accelerated drug release behavior.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom